DAM
OACC

DLD Asset Management’s Oaktree Acquisition Corp III Life Sciences OACC Stock Holding History

DLD Asset Management’s Portfolio OACC Stock Details OACC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-43,174
Closed -$32.4K – 499
2025
Q3 		$32.4K Hold
43,174
– – ﹤0.01% 311
2025
Q2 		$37.8K Buy
+43,174
New +$448K ﹤0.01% 247

Other funds holding OACC

AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
FBCM
Fort Baker Capital Management Larkspur, California $1.37B AUM 26.91% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.03B AUM 47.81% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
BGGS
Boussard & Gavaudan Gestion SAS Paris, France $1.99B AUM
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

DLD Asset Management's OACC Position: Q2 2026 in Review

DLD Asset Management increased its Oaktree Acquisition Corp III Life Sciences (OACC) stake by 21% in Q2 2026, buying an estimated $306K and bringing the position to 165,435 shares worth $1.77M. The position accounts for 0.12% of the portfolio, ranked #110.

DLD Asset Management first reported a position in OACC in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.58M in Q1 2025. 51 funds tracked by Wall St. Rank hold OACC as of Q2 2026.

  • DLD Asset Management held 165,435 shares of Oaktree Acquisition Corp III Life Sciences worth $1.77M as of Q2 2026.
  • DLD Asset Management bought 28,700 Oaktree Acquisition Corp III Life Sciences shares in Q2 2026, an estimated $306K.
  • Oaktree Acquisition Corp III Life Sciences made up 0.12% of DLD Asset Management's portfolio in Q2 2026, its #110 holding.
  • DLD Asset Management first reported a position in Oaktree Acquisition Corp III Life Sciences in Q4 2024 and has held it in 7 quarters since.
  • DLD Asset Management's Oaktree Acquisition Corp III Life Sciences position peaked at $3.58M in Q1 2025.
  • 51 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences as of Q2 2026.

Based on DLD Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.